Alanosine (also called SDX-102) is a substance that is being studied for the treatment of
pancreatic cancer. It is an
antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.
See more at Wikipedia.org...
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called antimetabolites. Also called alanosine.